Thijs Veerman

CEO

Catherinn BV

Leiden, Netherlands

7 profile visits

Catherinn develops immunotherapy and diagnostic solutions for Small Cell Lung Cancer patients with our proprietary NCAM180 biomarker

My organisation

Catherinn BV

Catherinn BV

Biotech company/R&D

Leiden, Netherlands

Catherinn BV (Cancer Therapeutics and Innovation) is a virtual research and development company devoted to the improvement of diagnostic and treatment options for Small Cell Lung Cancer (SCLC) patients. Catherinn was started by a group of highly motivated experts and entrepreneurs in the life science and vaccine industry. We are committed to improving the lives of SCLC cancer patients, both by prevention through early screening and by cure through immunotherapy.
Read more

About me

former CEO Netherlands Vaccine Institute

currently: CEO Catherinn and advisor to INFECTA (www.infecta.org)

Social media